BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28260065)

  • 1. FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide.
    Ma J; Li J; Yao X; Lin S; Gu Y; Xu J; Deng Z; Ma W; Zhang H
    Oncol Rep; 2017 Apr; 37(4):1935-1942. PubMed ID: 28260065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction rather than mtDNA sequence mutation is responsible for the multi-drug resistance of small cell lung cancer.
    Ma L; Wang R; Duan H; Nan Y; Wang Q; Jin F
    Oncol Rep; 2015 Dec; 34(6):3238-46. PubMed ID: 26502806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of novel microRNA targets in drug-sensitive and -insensitive small cell lung cancer cell lines.
    Ma L; Li P; Wang R; Nan Y; Liu X; Jin F
    Oncol Rep; 2016 Mar; 35(3):1611-21. PubMed ID: 26676926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
    Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
    Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
    Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
    Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
    Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
    Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FIGNL1 is a potential biomarker of cisplatin resistance in non-small cell lung cancer.
    Meng C; Yang Y; Ren P; Ju Q; Jin X; Long Q; Chen X; Wang X; Li F
    Int J Biol Markers; 2022 Sep; 37(3):260-269. PubMed ID: 35791674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fidgetin-like 1 gene inhibited by basic fibroblast growth factor regulates the proliferation and differentiation of osteoblasts.
    Park SJ; Kim SJ; Rhee Y; Byun JH; Kim SH; Kim MH; Lee EJ; Lim SK
    J Bone Miner Res; 2007 Jun; 22(6):889-96. PubMed ID: 17352653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A.
    Pan B; Chen Y; Song H; Xu Y; Wang R; Chen L
    Oncotarget; 2015 Jan; 6(1):317-31. PubMed ID: 25426560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.
    Allison Stewart C; Tong P; Cardnell RJ; Sen T; Li L; Gay CM; Masrorpour F; Fan Y; Bara RO; Feng Y; Ru Y; Fujimoto J; Kundu ST; Post LE; Yu K; Shen Y; Glisson BS; Wistuba I; Heymach JV; Gibbons DL; Wang J; Byers LA
    Oncotarget; 2017 Apr; 8(17):28575-28587. PubMed ID: 28212573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer cell proliferation.
    Li P; Ma L; Zhang Y; Ji F; Jin F
    Biomed Pharmacother; 2014 Feb; 68(1):7-12. PubMed ID: 24412084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide.
    Karachaliou N; Papadaki C; Lagoudaki E; Trypaki M; Sfakianaki M; Koutsopoulos A; Mavroudis D; Stathopoulos E; Georgoulias V; Souglakos J
    PLoS One; 2013; 8(9):e74611. PubMed ID: 24058603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
    Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
    Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
    Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
    Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chan-Yu-Bao-Yuan-Tang induces apoptosis in NSCLC and SCLC cell lines via a mitochondria-mediated pathway.
    Zhang Y; Zeng F; Liu X; Li Y; Zhou J; Huang Y; Wang Y; Zhou S; Zhu W; Shu E; Zhou G; Chen G
    Xenobiotica; 2011 Jul; 41(7):593-602. PubMed ID: 21446835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased insulin-like growth factor 1 receptor (IGF1R) expression in small cell lung cancer and the effect of inhibition of IGF1R expression by RNAi on growth of human small cell lung cancer NCI-H446 cell.
    Wang Z; Lu P; Liang Z; Zhang Z; Shi W; Cai X; Chen C
    Growth Factors; 2015; 33(5-6):337-46. PubMed ID: 26430715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer.
    Lai J; Yang H; Zhu Y; Ruan M; Huang Y; Zhang Q
    BMC Cancer; 2019 Jun; 19(1):602. PubMed ID: 31215481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evodiamine induces G2/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells.
    Fang C; Zhang J; Qi D; Fan X; Luo J; Liu L; Tan Q
    PLoS One; 2014; 9(12):e115204. PubMed ID: 25506932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
    Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
    Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.